Abbott Vascular
3200 Lakeside Dr.
Santa Clara, CA 95054
USA
Phone:
(408) 845-3000
Product Categories:
Related Content
News | Ventricular Assist Devices (VAD) | May 23, 2018
Abbott has initiated a Class I recall of the HeartMate 3 Left Ventricular Assist System due to a malfunction in the...
A MitraClip device being deployed to clasp together the leaflets of the mitral valve. This mimics a surgical suture repair to create a double orifice valve with better leaflet coaptation to prevent mitral regurgitation.
News | Structural Heart | May 11, 2018
May 11, 2018 — The post-approval study evaluating the safety and efficacy of MitraClip in a real-world, commercial se
News | Optical Coherence Tomography (OCT) | April 11, 2018
Abbott today announced the initiation of a clinical trial evaluating long-term outcomes of patients who undergo stent...
An example of Siemens' syngo CTO navigation technology that fuses computed tomogragraphy (CT) imaging with live angiography to help navigate chronic total occlusion vessel segments that are occluded and not visible on angiography alone.
Feature | Chronic Total Occlusion (CTO) | February 20, 2018 | Dave Fornell
One of the recent hot topics in interventional cardiology has been how operators can use new tools and techniques to
News | Antiplatelet and Anticoagulation Therapies | February 13, 2018
Abbott announced the first patient has been enrolled in a clinical trial evaluating 28 days of dual antiplatelet...
The bioresorbable Cordis MynxGrip vascular closure device seals arteriotomies without use of permanent hardware.
Feature | Vascular Closure Devices | January 22, 2018 | Dave Fornell
While manual compression remains the gold standard for hemostasis of catheterization vascular access site arteriotomi
Technology | EP Mapping and Imaging Systems | January 19, 2018
Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a...
The Abbott Absorb Bioresorbable Vascular Scaffold (BVS).
Feature | Stents Drug Eluting | January 17, 2018 | Dave Fornell
There was no shortage of interest in bioresorbable stent technologies at the many sessions offered on this topic or b
Technology | Cardiac Resynchronization Therapy Devices (CRT) | January 03, 2018
Abbott announced U.S. Food and Drug Administration (FDA) approval for magnetic resonance (MR)-conditional labeling for...
